North American cannabis stocks fly on DEA decision On Tuesday (April 30), news broke via a leak to the press
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-listed cannabis distributor Cantourage informed investors
APOLLON Formularies plc (AQSE: APOL) (“Apollon” or the “Company”), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, and Aion
Apollon Formularies plc (AQSE: APOL, “Apollon” or the “Company”), a UK based internationalpharmaceutical company trading on the Aquis Stock Exchange,
We start this week’s EU Cannabis Stocks Review with some breaking news from Oxford Cannabinoid Technologies, after the company’s co-founder calls for a general meeting in an attempt enact a dramatic management overhaul.
We won’t spam you
